Publications by authors named "Anders Boss"

Claim this Profile
M
Modeling the Effect of Subcutaneous Lixisenatide on Glucoregulatory Endocrine Secretions and Gastric Emptying in Type 2 Diabetes to Simulate the Effect of iGlarLixi Administration Timing on Blood Sugar Profiles.
Thibault Gautier, Rupesh Silwal, Aramesh Saremi, Anders Boss, Marc D Breton

J Diabetes Sci Technol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence of the effectiveness on glycaemic control of early simultaneous versus later sequential initiation of basal insulin and glucagon-like peptide-1 receptor agonists.
Julio Rosenstock, Francisco Javier Ampudia-Blasco, Robert Lubwama, Xuejun Victor Peng, Anders Boss

Diabetes Obes Metab· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study.
Xuejun Victor Peng, Rory J McCrimmon, Leah Shepherd, Anders Boss, Robert Lubwama

Diabetes Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK.
Aude Roborel de Climens, Emilie Pain, Anders Boss, Alka Shaunik

Diabetes Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA.
Lawrence Blonde, Luigi Meneghini, Xuejun Victor Peng, Anders Boss, Kyu Rhee

Diabetes Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence with rapid-acting insulin and its association with A1C level and severe hypoglycemia among elderly patients with type 2 diabetes.
Usha Sambamoorthi, Rahul Garg, Arijita Deb, Tao Fan, Anders Boss

Curr Med Res Opin· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Acting Insulin Use and Persistence among Elderly Type 2 Diabetes Patients Adding RAI to Oral Antidiabetes Drug Regimens.
Usha Sambamoorthi, Arijita Deb, Steve Zhou, Rahul Garg, Tao Fan, Anders Boss

J Diabetes Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin.
Lutz Heinemann, Robert Baughman, Anders Boss, Marcus Hompesch

J Diabetes Sci Technol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator.
Roberto Visentin, Clemens Giegerich, Robert Jäger, Raphael Dahmen, Anders Boss

Diabetes Technol Ther· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled insulin.
Philip A Levin, Lutz Heinemann, Anders Boss, Paul D Rosenblit

BMJ Open Diabetes Res Care· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technosphere insulin effectively controls postprandial glycemia in patients with type 2 diabetes mellitus.
Howard Zisser, Lois Jovanovic, Kateryna Markova, Richard Petrucci, Anders Boss

Diabetes Technol Ther· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coverage of prandial insulin requirements by means of an ultra-rapid-acting inhaled insulin.
Anders H Boss, Richard Petrucci, Daniel Lorber

J Diabetes Sci Technol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.
Julio Rosenstock, Daniel L Lorber, Luigi Gnudi, Campbell P Howard, David W Bilheimer, Anders H Boss

Lancet· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents.
Julio Rosenstock, Richard Bergenstal, Ralph A Defronzo, Irl B Hirsch, David Klonoff, Anders H Boss

Diabetes Care· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled Technosphere insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetes.
Klaus Rave, Tim Heise, Lutz Heinemann, Anders H Boss

J Diabetes Sci Technol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized forced titration to different doses of technosphere insulin demonstrates reduction in postprandial glucose excursions and hemoglobin A1c in patients with type 2 diabetes.
Cees J Tack, Vladimir Christov, Bastiaan E de Galan, Karl-Michael Derwahl, Gerhard Klausmann, Anders H Boss

J Diabetes Sci Technol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.
Klaus Rave, Tim Heise, Andreas Pfützner, Anders H Boss

Diabetes Care· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technosphere insulin technology.
Peter C Richardson, Anders H Boss

Diabetes Technol Ther· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variations of whole blood viscosity using Rheolog-a new scanning capillary viscometer.
Sihe Wang, Anders H Boss, Kenneth R Kensey, Robert S Rosenson

Clin Chim Acta· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis